Literature DB >> 20600328

Development of cell cultures that express hepatitis B virus to high levels and accumulate cccDNA.

Thomas B Lentz1, Daniel D Loeb.   

Abstract

Establishment of an infection with hepatitis B virus (HBV) requires synthesis and maintenance of a covalently closed circular DNA (cccDNA) form of the viral genome in the nucleus of host cells. To facilitate the investigation of the synthesis of cccDNA, cell cultures were developed that express HBV to high levels. Cell lines derived from hepatoma cells Huh7 and HepG2 were created that express Epstein-Barr virus (EBV) nuclear antigen-1 and a fusion protein of the Tet repressor and Kox1 transcriptional repression domain stably. Transfection of these cell lines with an expression plasmid for HBV that contains the origin of plasmid replication of EBV (oriP) led to increases in the intracellular levels of HBV core protein ( approximately 8- to 51-fold) and encapsidated HBV DNA ( approximately 3- to 12-fold) in comparison to Huh7 and HepG2 cells. Virion production was also increased ( approximately 3- to 12-fold) in these cell cultures and an increase in the level of cccDNA ( approximately 3-fold) was observed in the Huh7-derived cell lines. In addition, these cell lines maintained the HBV expression plasmid upon selection and expressed HBV conditionally. Thus, these cell cultures exhibit several features that facilitate study of the synthesis of cccDNA and other aspects of replication of HBV. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600328      PMCID: PMC2930070          DOI: 10.1016/j.jviromet.2010.06.015

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  40 in total

1.  Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles.

Authors:  J Summers; A O'Connell; I Millman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

2.  Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification.

Authors:  J Summers; P M Smith; A L Horwich
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

4.  In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway.

Authors:  T T Wu; L Coates; C E Aldrich; J Summers; W S Mason
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

5.  The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly.

Authors:  M Nassal
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.

Authors:  J S Tuttleman; C Pourcel; J Summers
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

7.  Experimental transmission of duck hepatitis B virus.

Authors:  W S Mason; M S Halpern; J M England; G Seal; J Egan; L Coates; C Aldrich; J Summers
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

8.  Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide.

Authors:  P Gripon; C Diot; N Thézé; I Fourel; O Loreal; C Brechot; C Guguen-Guillouzo
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver.

Authors:  R H Miller; W S Robinson
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

10.  Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

Authors:  Bettina Werle-Lapostolle; Scott Bowden; Stephen Locarnini; Karsten Wursthorn; Jorg Petersen; George Lau; Christian Trepo; Patrick Marcellin; Zachary Goodman; William E Delaney; Shelly Xiong; Carol L Brosgart; Shan-Shan Chen; Craig S Gibbs; Fabien Zoulim
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

View more
  7 in total

1.  Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms.

Authors:  Purnima Bhat; Michelle J Snooks; David A Anderson
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus.

Authors:  Thomas B Lentz; Daniel D Loeb
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

3.  The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies.

Authors:  Liesbeth Ceelen; Marusya Lieveld; Ramses Forsyth; Mathieu Vinken
Journal:  Hepatol Int       Date:  2013-02-14       Impact factor: 6.047

4.  Encapsidated hepatitis B virus reverse transcriptase is poised on an ordered RNA lattice.

Authors:  Joseph Che-Yen Wang; David G Nickens; Thomas B Lentz; Daniel D Loeb; Adam Zlotnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-17       Impact factor: 11.205

5.  Effects of hepatitis B virus mutations on its replication and liver disease severity.

Authors:  Abdulrahim Hakami; Abdelwahid Ali; Ahmed Hakami
Journal:  Open Virol J       Date:  2013-01-23

6.  DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels.

Authors:  Kazuma Sekiba; Motoyuki Otsuka; Motoko Ohno; Takahiro Kishikawa; Mari Yamagami; Tatsunori Suzuki; Rei Ishibashi; Takahiro Seimiya; Eri Tanaka; Kazuhiko Koike
Journal:  Oncotarget       Date:  2018-04-20

7.  Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction.

Authors:  Kazuma Sekiba; Motoyuki Otsuka; Motoko Ohno; Mari Yamagami; Takahiro Kishikawa; Tatsunori Suzuki; Rei Ishibashi; Takahiro Seimiya; Eri Tanaka; Kazuhiko Koike
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.